Timothy J. Patrick
President and Chief Executive Officer, Carticept Medical
Prior to founding Carticept Medical, Inc., Tim was President, CEO and co-founder of Proxima Therapeutics, Inc., a company focused on the localized delivery of radiation for the treatment of cancer. Proxima was acquired by Cytyc Corporation in March 2005 at one of the highest device multiples in the last five years. Prior to co-founding Proxima Therapeutics in 1996, Mr. Patrick was President of Gesco International, the leading manufacturer of peripherally inserted central venous catheters. Gesco and its parent company, MedChem Products, were acquired by CR Bard in 1995. Before serving as President of Gesco International, Mr. Patrick ran two high growth divisions for McGaw Inc., serving most recently as President of Central Admixture Pharmacy Services, an oncology drug provider, and as Vice President and General Manager of the Alternate Site Division. He also held a number of sales and sales management positions at American Hospital Supply Corporation. Tim has served on the Board of Directors of the Advanced Medical Technology Association (AdvaMed). He is currently on the Board of the Georgia Biomedical Partnership and a member of the Directors Circle at Yerkes National Primate Research Center. He is an inventor on several patents related to localized radiation delivery systems. Mr. Patrick earned his BA in Zoology from Miami University in Ohio.
